Posted by admin on Jun 24th, 2022
Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) reached a new 52-week low on Wednesday . The stock traded as low as $29.81 and last traded at $30.57, with a volume of 27838 shares trading hands. The stock had previously closed at $30.36.
Several research firms recently commented on BBWI. Barclays reduced their price target on Bath & Body Works from $53.00 to $40.00 and set an “equal weight” rating on the stock in a research report on Friday, May 20th. Cowen reduced their price target on Bath & Body Works from $82.00 to $60.00 and set an “outperform” rating on the stock in a research report on Friday, May 20th. MKM Partners reduced their price target on Bath & Body Works from $94.00 to $91.00 and set a “buy” rating on the stock in a research report on Thursday, February 24th. JPMorgan Chase & Co. reduced their price target on Bath & Body Works from $81.00 to $67.00 in a research report on Monday, May 16th. Finally, Credit Suisse Group reduced their price target on Bath & Body Works from $64.00 to $49.00 and set a “neutral” rating on the stock in a research report on Thursday, May 19th. Two equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $66.47.
The firm has a market capitalization of $6.76 billion, a P/E ratio of 6.44, a P/E/G ratio of 0.91 and a beta of 1.58. The stock has a fifty day moving average price of $43.92 and a two-hundred day moving average price of $52.31.
Bath & Body Works (NYSE:BBWI – Get Rating) last issued its quarterly earnings results on Wednesday, May 18th. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.13. Bath & Body Works had a negative return on equity of 69.03% and a net margin of 15.41%. The business had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.43 billion. Analysts expect that Bath & Body Works, Inc. will post 4.01 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Friday, June 17th. Stockholders of record on Friday, June 3rd were issued a $0.20 dividend. The ex-dividend date of this dividend was Thursday, June 2nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.71%. Bath & Body Works’s dividend payout ratio (DPR) is 17.43%.
In related news, CFO Wendy C. Arlin sold 6,000 shares of Bath & Body Works stock in a transaction dated Tuesday, April 19th. The shares were sold at an average price of $55.00, for a total value of $330,000.00. Following the sale, the chief financial officer now directly owns 98,888 shares in the company, valued at approximately $5,438,840. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Thomas E. Mazurek sold 16,338 shares of Bath & Body Works stock in a transaction dated Friday, May 27th. The shares were sold at an average price of $42.25, for a total transaction of $690,280.50. Following the completion of the sale, the insider now owns 11,225 shares in the company, valued at $474,256.25. The disclosure for this sale can be found here. 0.37% of the stock is currently owned by insiders.
A number of large investors have recently modified their holdings of the stock. State Street Corp lifted its position in Bath & Body Works by 3.8% in the 4th quarter. State Street Corp now owns 11,173,734 shares of the company’s stock valued at $779,815,000 after purchasing an additional 412,656 shares during the last quarter. Steadfast Capital Management LP raised its position in shares of Bath & Body Works by 7,923.4% during the 1st quarter. Steadfast Capital Management LP now owns 6,760,507 shares of the company’s stock worth $323,152,000 after buying an additional 6,676,247 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Bath & Body Works by 1.9% during the 4th quarter. Geode Capital Management LLC now owns 4,966,256 shares of the company’s stock worth $345,713,000 after buying an additional 91,300 shares in the last quarter. Northern Trust Corp raised its position in shares of Bath & Body Works by 5.3% during the 4th quarter. Northern Trust Corp now owns 3,022,119 shares of the company’s stock worth $210,914,000 after buying an additional 152,431 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its position in shares of Bath & Body Works by 34.5% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,830,984 shares of the company’s stock worth $135,321,000 after buying an additional 726,384 shares in the last quarter. Hedge funds and other institutional investors own 97.11% of the company’s stock.
About Bath & Body Works (NYSE:BBWI)
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
Stanley Black & Decker (NYSE:SWK) Given New $122.00 Price Target at The Goldman Sachs Group
Helios Technologies (NASDAQ:HLIO) Sets New 1-Year Low at $60.89